|Last Price||Today's Change||52-Week Range||Trading Volume|
|129.36||-3.70 (-2.78%)||97.45 - 143.45||1.3 million|
Market data as of 4:00PM 11/30/15. Quotes are delayed by at least 15 min.
Vertex to Present at the Piper Jaffray Healthcare Conference on December 1
11/23/2015 4:01 PM ET
Vertex Receives EU Approval for ORKAMBI® (lumacaftor/ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis in People Ages 12 and Older with Two Copies of the F508del Mutation
11/20/2015 3:30 AM ET